Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-054820
Filing Date
2025-03-14
Accepted
2025-03-14 16:22:46
Documents
4
Effectiveness Date
2025-03-14

Document Format Files

Seq Description Document Type Size
1 S-8 d864612ds8.htm S-8 32847
2 EX-5.1 d864612dex51.htm EX-5.1 4642
3 EX-23.1 d864612dex231.htm EX-23.1 1564
4 EX-FILING FEES d864612dexfilingfees.htm EX-FILING FEES 15594
  Complete submission text file 0001193125-25-054820.txt   55898
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285827 | Film No.: 25740325
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)